5 Best Healthcare Technology Stocks To Invest In 2015: ARIAD Pharmaceuticals Inc.(ARIA)
ARIAD Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company?s lead cancer product, ridaforolimus is being studied in multiple clinical trials in patients with various types of cancers, including metastatic sarcomas, breast cancer, endometrial cancer, prostate cancer, and non-small cell lung cancer. Its product pipeline also includes ponatinib, a pan BCR-ABL inhibitor in phase 2 clinical trial for applications in various hematological cancers and solid tumors; and AP26113, an anaplastic lymphoma kinase inhibitor in preclinical studies for the treatment of various cancers, including non-small cell lung cancer, lymphoma, and neuroblastoma. In addition, the company focuses on a drug discovery program centered on small-molecule therapies that are molecularly targeted to cell-signaling pathways implicated in cancer. Further, it licenses its ARGENT cell-sign aling regulation technologies to pharmaceutical and biotechnology companies to develop and commercialize therapeutic products, and to conduct drug discovery research. The company has collaboration and license agreements with Merck & Co., Inc. for the development, manufacture, and commercialization of ridaforolimus; and license agreements with Medinol Ltd. and ICON Medical Corp. to develop and commercialize stents and other medical devices to deliver ridaforolimus to prevent restenosis of injured vessels. ARIAD Pharmaceuticals, Inc. was founded in 1991 and is based in Cambridge, Massachusetts.
Advisors' Opinion:- [By Paul Ausick]
Stocks on the Move: Voxeljet AG (NYSE: VJET) is up 121.8% at $28.83 after a blazing hot IPO. Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) is down 40.7% at $2.67 on a failed drug trial. ParkerVision Inc. (NASDAQ: PRKR) is up 17.9% at $6.40 after gaining more than 60% yesterday on ! a Florida jurys ruling in the companys favor in a patent suit against Qualcomm Inc. (NASDAQ: QCOM). J.C. Penney Co. Inc. (NYSE: JCP) is down 4.8% at $7.00, after posting a 33-year low of $6.97 a share earlier today.
- [By Paul Ausick]
Stocks on the Move: Nuance Communications Inc. (NASDAQ: NUAN) is down 18.1% at $13.10 and Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) is down 9% at $4.67 on huge volume today. Mediabistro Inc. (NASDAQ: MBIS) is up 87.2% at $4.10 after investing in a media and events firm that covers the 3D printing market.
- [By Paul Ausick]
Stocks on the Move: Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) is up 35.7% at $5.13. Camtek Inc. (NASDAQ: CAMT) is up 71.7% at $4.55 after saying that a 3D printer is coming next year from the company. Sungy Mobile Ltd. (NASDAQ: GOMO) is up 28.8% at $17.19 after last Fridays IPO. InterCloud Systems Inc. (NASDAQ: ICLD) is down 28.2% at $9.20.
- [By George Budwell]
Ariad Pharmaceuticals (NASDAQ: ARIA ) is an oncology company whose leukemia drug Iclusig made headlines recently when it was pulled from the market by the Food and Drug Administration after a late-stage trial showed an elevated risk of blood clots. Shares of Ariad fell more than 25% this week as a result, despite already being down more than 80% in the last month. The problem facing Ariad is clear: Iclusig is its bread and butter. So if the FDA does not allow it back on the market, and that looks doubtful at this point, Ariad is in big trouble. Currently, the company only has one other clinical candidate, and that drug is still in the very early stages of development.
source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/5-best-healthcare-technology-stocks-to-invest-in-2015-2.html
No comments:
Post a Comment